Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ropivacaine for Postoperative Pain After Wisdom Tooth Extraction
NCT07844824Phase 4Completed
- Sponsor
- University of Zagreb
- Start
- Oct 2023
- Primary completion
- Aug 2024
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of ropivacaine in postoperative pain (2 arms), sponsored by University of Zagreb. Primary endpoint: Postoperative Pain Intensity as Assessed by the Visual Analogue Scale at 72 hours. Started Oct 2023; status: completed.
02
Drugs
ropivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT07844824.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07844824.